“Andexxa was the antidote for major bleeding complications caused by Xarelto and Eliquis, both intracerebral and intra-abdominal. Andexxa stopped the bleeding but caused blood clots 2.1x more than usual care and 2.8x more deaths than usual care.” Greg Vigna, MD, JD, national pharmaceutical injury attorney.
Vigna Law Group announces clinical criteria for case evaluation:
“This is a terrible drug, and clearly AstraZeneca has many questions to answer. How could a drug that causes twice as many thrombotic complications with routine use, and nearly 3x the risk of death, get into the veins of patients who are seriously ill with major bleeding complications?”
Dr. Vigna
“Andexxa was an antidote for major bleeding complications caused by Xarelto and Eliquis, including intracerebral and intra-abdominal. While Andexxa stopped the bleeding, it was associated with a 2.1-fold increase in blood clots and a 2.8-fold increase in deaths compared with usual care,” states Greg Vigna, MD, JD, national pharmaceutical injury attorney. Click here to read the […]
“The FDA’s decision to withdraw Andexxa from the market underscores a critical failure in post-market surveillance and patient safety,” states Greg Vigna, MD, JD, national medical malpractice attorney. The U.S. Food and Drug Administration announced on December 18, 2025, that Andexxa (coagulation factor Xa recombinant, inactivated-zhzo) will be withdrawn from the U.S. market following alarming […]
8939 S. Sepulveda Blvd. Suite 102
Los Angeles, CA, 90045
Dr. Greg Vigna, is the principal of Greg Vigna, MD, JD, PLC, a California personal injury law firm, and his law firm has a non-exclusive referral relationship with the attorneys listed within this site. Dr. Vigna, co-counsels with attorneys across the country.